Salil Patel

Salil brings a wealth of experience in global Medical Affairs, working with cross-functional teams in Commercial, Market Access as well as R&D. He joins us from BMS where he held various roles leading medical strategy for their Oncology and Immunoscience assets. Salil served as Head of Medical for the Oncology business of BMS, supporting the launch of Opdivo in several indications for major markets globally. One of his key accomplishments in this role was to form the Global Expert Centers Initiative - a collaborative network with 21 European leading academic institutes. He was also Head of Precision Medicine, where he worked with R&D and Commercial to implement into practice disease-related biomarkers in oncology.

Salil received his Ph.D. in Biochemistry from the University of Southampton, UK and had significant post-doctoral experience in Molecular Biology from Caltech and Immunology from Stanford University.